BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27212282)

  • 1. Efficacy and relapse rates of different treatment modalities for progressive macular hypomelanosis.
    Thng ST; Long VS; Chuah SY; Tan VW
    Indian J Dermatol Venereol Leprol; 2016; 82(6):673-676. PubMed ID: 27212282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive macular hypomelanosis, excellent response with narrow-band ultraviolet B phototherapy.
    Montero LC; Belinchón I; Toledo F; Betlloch I
    Photodermatol Photoimmunol Photomed; 2011 Jun; 27(3):162-3. PubMed ID: 21535172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive macular hypomelanosis.
    Elmariah SB; Kundu RV
    J Drugs Dermatol; 2011 May; 10(5):502-6. PubMed ID: 21533296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive macular hypomelanosis in korean patients: a clinicopathologic study.
    Hwang SW; Hong SK; Kim SH; Park JH; Seo JK; Sung HS; Lee D
    Ann Dermatol; 2009 Aug; 21(3):261-7. PubMed ID: 20523800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive macular hypomelanosis: an epidemiological study and therapeutic response to phototherapy.
    Duarte I; Nina BI; Gordiano MC; Buense R; Lazzarini R
    An Bras Dermatol; 2010; 85(5):621-4. PubMed ID: 21152785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive macular hypomelanosis in a 16-year old.
    Perman M; Sheth P; Lucky AW
    Pediatr Dermatol; 2008; 25(1):63-5. PubMed ID: 18304157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study.
    Relyveld GN; Kingswijk MM; Reitsma JB; Menke HE; Bos JD; Westerhof W
    J Am Acad Dermatol; 2006 Nov; 55(5):836-43. PubMed ID: 17052490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of progressive macular hypomelanosis with narrow-band ultraviolet B phototherapy.
    Kwah YC; Chong WS; Thiam-Seng Theng C; Goh BK
    Photodermatol Photoimmunol Photomed; 2010 Jun; 26(3):153-5. PubMed ID: 20584255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adolescent extra-truncal progressive macular hypomelanosis.
    Paquette GM; Sherman S; Akabane A; Harris JE
    Pediatr Dermatol; 2023; 40(4):702-705. PubMed ID: 36744793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-fungal resistant hypopigmented macules in an adolescent].
    Martínez Martínez ML; Azaña Defez JM; López Villaescusa MT; Gómez Sánchez M
    Semergen; 2012 Sep; 38(6):405-7. PubMed ID: 22935838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible role of antiretroviral drugs in the pathogenesis of progressive macular hypomelanosis.
    Lo Schiavo A; Gambardella A; Caccavale S
    Int J Dermatol; 2014 Jun; 53(6):759-60. PubMed ID: 23786465
    [No Abstract]   [Full Text] [Related]  

  • 12. Progressive macular hypomelanosis arising in a young African American woman in association with pregnancy and a toxic nodular goiter.
    Tierney EP; Hamzavi I
    J Drugs Dermatol; 2010 Apr; 9(4):393-7. PubMed ID: 20514800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive macular hypomelanosis.
    Martínez-Martínez ML; Azaña-Defez JM; Rodríguez-Vázquez M; Faura-Berruga C; Escario-Travesedo E
    Pediatr Dermatol; 2012; 29(4):460-2. PubMed ID: 21995551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypopigmented macules of photodamaged skin and their treatment with topical tretinoin.
    Pagnoni A; Kligman AM; Sadiq I; Stoudemayer T
    Acta Derm Venereol; 1999 Jul; 79(4):305-10. PubMed ID: 10429990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of topical combination of benzoyl peroxide 5% and clindamycin 1% for the treatment of progressive macular hypomelanosis: a randomized, doubleblind, placebo-controlled trial.
    Santos JB; Almeida OL; Silva LM; Barreto ER
    An Bras Dermatol; 2011; 86(1):50-4. PubMed ID: 21437522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired disorders with hypopigmentation: A clinical approach to diagnosis and treatment.
    Saleem MD; Oussedik E; Picardo M; Schoch JJ
    J Am Acad Dermatol; 2019 May; 80(5):1233-1250.e10. PubMed ID: 30236514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of progressive macular hypomelanosis.
    Leonard N; Krueger S; Rashighi M
    Dermatol Reports; 2020 Sep; 12(2):8509. PubMed ID: 33408831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive macular hypomelanosis: an overview.
    Relyveld GN; Menke HE; Westerhof W
    Am J Clin Dermatol; 2007; 8(1):13-9. PubMed ID: 17298102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive macular hypomelanosis in Singapore: a clinico-pathological study.
    Kumarasinghe SP; Tan SH; Thng S; Thamboo TP; Liang S; Lee YS
    Int J Dermatol; 2006 Jun; 45(6):737-42. PubMed ID: 16796639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of progressive macular hypomelanosis treated with 1% topical clindamycin lotion and narrow-band ultraviolet B.
    Erpolat S; Gorpelioglu C; Sarifakioglu E
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):277-8. PubMed ID: 20831700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.